Why Dr. Younes Uses Social Media (Bunny Ellerin) offers a great example of the broader potential of social media beyond simply a pharma marketer’s focus on building patient dialogue and retention or to keep current with old and new friends.
The story begins with Dr. Younes from The University of Texas MD Anderson Cancer Center with his recent blog Medicine and Social Media: Why do I tweet?
“Two years ago, I decided to experiment with social media. I have a strong interest in the treatment of Hodgkin’s lymphoma, a rare type of human cancer that affects approximately 8,600 patients per year in the United States. With a cure rate of 75%, it was very challenging to get pharmaceutical companies interested in developing new therapies for this small patient population. Furthermore, because of the limited pool of patients who are eligible for experimental therapy, these trials traditionally never enrolled patients in a timely manner.”
Then Dr Younes secured four IRB approved trials, and needed to enroll patients and tried many recruiting methods… Continue reading